Roche (ROG: SIX) has discontinued two Huntington’s disease programs, ending the long-running development of tominersen after ...

The demise of the two programmes still leaves Roche with one Huntington's candidate, the gene therapy RG6662, which is in a ...

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented today at the ISSCR 2026 Annual Meeting.

Roche has halted development on two of its Huntington’s disease prospects, delivering another blow to a patient community that has long awaited new medicines. The Swiss drugmaker explained its ...

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's ...

A genetic disorder, Huntington’s leads to the breakdown of nerves and a progressive inability to think, move and function. No treatment has so far been approved to slow the condition’s march, although ...

Prilenia Therapeutics and Ferrer have begun the confirmatory Phase III PRECISE-HD clinical trial assessing pridopidine as a ...

PRECISE-HD Study. Focused on further evaluating the efficacy and safety of pridopidine, an investigational medicinal product ...

General Hospital recaps for Monday, July 6 reveal Rocco Falconeri (Finn Carr) thanked Dante Falconeri (Dominic Zamprogna) as ...

A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time ...

Britt’s Huntington’s diagnosis was a major part of her original story line. It also became the driving force behind her return after her “death.” Back in 2023, when Britt was attacked by the serial ...